Xuzhou, China

Xiaoxia Zhu

USPTO Granted Patents = 1 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Xiaoxia Zhu in Pharmaceutical Composition

Introduction

Xiaoxia Zhu is a prominent inventor based in Xuzhou, China. She has made significant contributions to the field of pharmaceuticals, particularly in the area of pain management. Her innovative work focuses on addressing the challenges associated with morphine-induced analgesic tolerance.

Latest Patents

Xiaoxia Zhu holds a patent for a pharmaceutical composition and method for relieving or eliminating morphine-induced analgesic tolerance. The patent discloses a pharmaceutical composition that includes a therapeutically effective amount of a short peptide and morphine as active ingredients, along with a pharmaceutically-acceptable carrier. The short peptide consists of an amino acid sequence shown in SEQ ID NO: 1 or a pharmaceutically-acceptable salt thereof. The method involves administering the short peptide and morphine to a subject simultaneously, injecting the short peptide followed by morphine, or administering a pharmaceutical composition that includes both.

Career Highlights

Xiaoxia Zhu is affiliated with Xuzhou Medical University, where she continues her research and development in pharmaceutical sciences. Her work has garnered attention for its potential to improve pain management therapies and enhance patient outcomes.

Collaborations

Xiaoxia collaborates with notable colleagues, including Qiongyao Tang and Zhe Zhang, who contribute to her research efforts and innovations in the field.

Conclusion

Xiaoxia Zhu's contributions to pharmaceutical compositions demonstrate her commitment to advancing pain management solutions. Her innovative approaches have the potential to significantly impact the treatment of patients experiencing morphine-induced analgesic tolerance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…